FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Hiroshi Yasui

Research Profile

Chemicals & Drugs

Disorders

Multiple Myeloma

Physiology

Anatomy

Procedures

Concepts & Ideas

Treatment Outcome

Living Beings

Mouse

Co-author Network

Publications

TOP 3
Yumiko Maruyama; Toshiaki Hayashi; Hiroshi Ikeda; Tadao Ishida; Hiroshi Yasui; Yasuhisa Shinomura
Usefulness of serum free light-chain assay for evaluation of therapeutic efficacy in non-secretory multiple myeloma.
Hiroshi Yasui; Toshiaki Hayashi; Hiroshi Ikeda; Tadao Ishida; Reo Maruyama; Masanori Nojima; Yasuhisa Shinomura; Hiromu Suzuki; Kohzoh Imai
Model of translational cancer research in multiple myeloma.
Tetsuyuki Igarashi; Hiroshi Ikeda; Tadao Ishida; Tohru Takahashi; Hiroshi Yasui; Toshiaki Hayashi; Yasuhisa Shinomura
[Sustained complete molecular remission after cessation of imatinib mesylate treatment in a patient with relapsed chronic myelogenous leukemia after allogeneic stem cell transplantation].

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Hiroshi Yasui (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Yumiko Maruyama; Toshiaki Hayashi; Hiroshi Ikeda; Tadao Ishida; Hiroshi Yasui; Yasuhisa Shinomura
Usefulness of serum free light-chain assay for evaluation of therapeutic efficacy in non-secretory multiple myeloma.
[Rinshō ketsueki] The Japanese journal of clinical hematology 2013;54(1):122-6.
2012: Hiroshi Yasui; Toshiaki Hayashi; Hiroshi Ikeda; Tadao Ishida; Reo Maruyama; Masanori Nojima; Yasuhisa Shinomura; Hiromu Suzuki; Kohzoh Imai
Model of translational cancer research in multiple myeloma.
Cancer science 2012;103(11):1907-12.
2012: Tetsuyuki Igarashi; Hiroshi Ikeda; Tadao Ishida; Tohru Takahashi; Hiroshi Yasui; Toshiaki Hayashi; Yasuhisa Shinomura
[Sustained complete molecular remission after cessation of imatinib mesylate treatment in a patient with relapsed chronic myelogenous leukemia after allogeneic stem cell transplantation].
[Rinshō ketsueki] The Japanese journal of clinical hematology 2012;53(2):215-8.
2011: Toshiaki Hayashi; Hiroshi Yasui; Kentaro Kawakami; Hiroshi Ikeda; Fumihiko Takahashi; Toshihisa Kobayashi; Susumu Nishimura; Tadao Ishida; Kohzoh Imai; Yasuhisa Shinomura
[Bortezomib plus dexamethasone treatment followed by reduced-intensity allogeneic stem cell transplantation for multiple myeloma refractory to high-dose chemotherapy with autologous transplantation].
[Rinshō ketsueki] The Japanese journal of clinical hematology 2011;52(3):136-41.
2011: Shigeru Sasaki; Tadao Ishida; Minoru Toyota; Akinobu Ota; Hiromu Suzuki; Akinori Takaoka; Hiroshi Yasui; Hiroyuki Yamamoto; Hideyasu Takagi; Masahiro Maeda; Tsutomu Seito; Masayuki Tsujisaki; Yasuhisa Shinomura; Kohzoh Imai
Interferon-α/β and anti-fibroblast growth factor receptor 1 monoclonal antibody suppress hepatic cancer cells in vitro and in vivo.
PloS one 2011;6(5):e19618.
2009: Masanori Nojima; REO MARUYAMA; Hiroshi Yasui; Hiromu Suzuki; Yumiko Maruyama; Isao Tarasawa; Yasushi Sasaki; Hideki Asaoku; Hajime Sakai; Toshiaki Hayashi; Mitsuru Mori; Kohzoh Imai; Takashi Tokino; Tadao Ishida; Minoru Toyota; Yasuhisa Shinomura
Genomic screening for genes silenced by DNA methylation revealed an association between RASD1 inactivation and dexamethasone resistance in multiple myeloma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(13):4356-64.
2007: Mayuko Saito; Toshiaki Hayashi; Masahiro Nojima; Hiroshi Ikeda; Isao Tarasawa; Hiroshi Yasui; Tadao Ishida; Masaaki Adachi; Kohzoh Imai; Yasuhisa Shinomura
[Long-term survival after autologous peripheral blood stem cell transplantation in a patient with primary AL amyloidosis complicating congestive heart failure].
[Rinshō ketsueki] The Japanese journal of clinical hematology 2007;48(11):1478-83.
2005: Hiroshi Ikeda; Toshiaki Hayashi; Masahiro Nojima; Hiroshi Yasui; Yukiho Ikeda; Tadao Ishida; Masaaki Adachi; Kohzoh Imai
[Effective combination therapy of bortezomib and dexamethasone for two patients with refractory multiple myeloma].
[Rinshō ketsueki] The Japanese journal of clinical hematology 2005;46(4):269-73.
2003: Hiroshi Yasui; Masaaki Adachi; Kohzoh Imai
Combination of tumor necrosis factor-alpha with sulindac in human carcinoma cells in vivo.
Annals of the New York Academy of Sciences 2003;1010():273-7.
2003: Masashi Idogawa; Masaaki Adachi; Takae Minami; Hiroshi Yasui; Kohzoh Imai
Overexpression of BAD preferentially augments anoikis.
International journal of cancer. Journal international du cancer 2003;107(2):215-23.
2003: Hiroshi Yasui; Masaaki Adachi; Kohzoh Imai
Combination of tumor necrosis factor-alpha with sulindac augments its apoptotic potential and suppresses tumor growth of human carcinoma cells in nude mice.
Cancer 2003;97(6):1412-20.